Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies

Figure 1

Summary of phase III trials investigating the use of antiresorptive drugs in the context of castration sensitive and castration resistant prostate cancer (PC) with and without bone metastases. SRE: skeletal related event.